Option Care Health, Inc.
OPCHHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframePart of the healthcare sector, Option Care Health, Inc. (OPCH) is listed under Medical Care Facilities. The $3.63B market capitalization puts OPCH squarely in mid-cap range for its industry. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Market Cap
$3.63B
Beta
0.61
P/E (TTM)
18.34
P/E (Fwd)
11.63
EPS (TTM)
$1.32
EPS (Fwd)
$2.08
ROE
16.0%
ROA
6.2%
Cash
$196.8M
Total Debt
$1.27B
Free CF
$256.1M
52W Change
-17.3%
Annual Financials
Cash vs Debt
Where OPCH stands vs its 150-day and 200-day moving averages
As of the August 20, 2026 close, OPCH finished 11.35% below its 150-day moving average ($26.34) and 14.84% below its 200-day moving average ($27.42). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OPCH overbought or oversold?
At the August 20, 2026 close, OPCH's RSI(14) was 61.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, OPCH has $196.8M in cash with $1.27B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $256.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 16.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $3.44B (2021) to $5.65B (2025), reflecting a 64% increase over the period.
The relatively low beta of 0.61 suggests OPCH is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing OPCH.